Covariate | M0 (n = 144) | M1 (n = 144) | M2 (n = 139) | M3 (n = 131) |
---|---|---|---|---|
Erlangen Score (reference category: Improbable AD) | ||||
Possible AD | ||||
Before 3-year follow-up | 7.67 (2.08–28.27)* | 7.75 (2.05–29.27)* | 7.43 (1.95–28.37)* | 5.68 (1.47–21.97)* |
After 3-year follow-up | 1.04 (0.20–5.47) | 1.04 (0.20–5.50) | 0.94 (0.18–4.99) | 0.92 (0.17–4.91) |
Probable AD | 12.0 (3.67–39.46)* | 12.3 (3.60–42.19)* | 10.8 (3.09–37.38)* | 8.09 (2.29–28.56)* |
Age (years) | – | 1.00 (0.97–1.03) | 1.00 (0.97–1.03) | 1.00 (0.96–1.03) |
Female gender | – | 1.10 (0.68–1.81) | 1.07 (0.66–1.75) | 1.05 (0.63–1.75) |
APOE ε4 presence | – | – | 1.42 (0.86–2.36) | 1.48 (0.88–2.48) |
MMSE | – | – | – | 0.95 (0.87–1.02) |
Log likelihood | − 284.0 | − 283.9 | − 280.6 | − 264.5 |